75 results
8-K
EX-99.1
IMNM
Immunome, Inc.
12 Aug 24
Immunome Reports Second Quarter 2024 Financial Results and Provides Business Update
4:05pm
assets
Restricted cash
Other long-term assets
Total assets
Liabilities and stockholders’ equity
Current liabilities:
Accounts payable
Accrued expenses
8-K
EX-99.1
3ptwf0tm
14 May 24
Immunome Reports First Quarter 2024 Financial Results and Provides Business Update
8:02am
8-K
EX-99.1
zbcju1x5o1gn
28 Mar 24
Immunome Reports Full-Year 2023 Financial Results and Provides Update on Recently Acquired Assets
4:04pm
8-K
EX-1.1
9s6 mbk68fggrm0avcr
14 Feb 24
Other Events
4:11pm
424B5
udu kc7tj2aas7
14 Feb 24
Prospectus supplement for primary offering
4:09pm
424B5
s8u0aam5ii gt25hsze9
13 Feb 24
Prospectus supplement for primary offering
4:36pm
8-K
EX-99.1
52syb6nayj wcc4q1qik
13 Feb 24
Results of Operations and Financial Condition
4:10pm